Concurrent Oral UFT and Pelvic Irradiation as Neoadjuvant Chemoradiation for Operable Rectal Cancer
Amal Abd Al Samee Saeed;
Abstract
Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with over 1.2 million new cancer cases and 608,700 deaths estimated to have occurred in 2008 (Jemal et al., 2011).
The American Cancer Society estimates that
The American Cancer Society estimates that
Other data
| Title | Concurrent Oral UFT and Pelvic Irradiation as Neoadjuvant Chemoradiation for Operable Rectal Cancer | Other Titles | العلاج المتشارك بواسطة عقار اليو إف تى عن طريق الفم مع العلاج الإشعاعى للحوض كعلاج مبدئى كيميائى إشعاعى لحالات أورام المستقيم القابلة للتدخل الجراحى | Authors | Amal Abd Al Samee Saeed | Keywords | Concurrent Oral UFT and Pelvic Irradiation as Neoadjuvant Chemoradiation for Operable Rectal Cancer | Issue Date | 2011 | Description | Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with over 1.2 million new cancer cases and 608,700 deaths estimated to have occurred in 2008 (Jemal et al., 2011). The American Cancer Society estimates that |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.